17 Jul, EOD - Indian

Nifty Pharma 22680.35 (0.38)

Nifty Smallcap 100 19117.3 (-0.12)

SENSEX 82259.24 (-0.45)

Nifty Bank 56828.8 (-0.59)

Nifty 50 25111.45 (-0.40)

Nifty Midcap 100 59519.1 (-0.17)

Nifty IT 37138.55 (-1.39)

Nifty Next 50 68711.45 (-0.23)

17 Jul, EOD - Global

NIKKEI 225 39901.19 (0.60)

HANG SENG 24498.96 (-0.08)

S&P 6297.01 (0.20)

LOGIN HERE
LOGIN HERE

companylogoWindlas Biotech Ltd

You are Here : Home > Markets > Company Information > Profit and Loss
BSE Code : 543329 | NSE Symbol : WINDLAS | ISIN : INE0H5O01029 | Industry : Pharmaceuticals - Indian - Formulations |
Profit and Loss
Particulars (₹ Cr)Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Revenue From Operations 759.88630.96513.08465.93427.60
Sale of Products754.36626.78508.61461.44424.73
Sale of Services0.772.111.971.941.98
Income from Investment and Financial Services0.000.000.000.000.00
Income from Insurance Operations0.000.000.000.000.00
Other Operating Revenue4.752.072.502.560.89
Less: Excise Duty / GST0.000.000.000.000.00
Revenue From Operations - Net759.88630.96513.08465.93427.60
Other Income17.6513.479.976.713.09
Total Revenue777.52644.42523.05472.64430.70
Changes in Inventories-21.529.59-15.27-4.743.67
Cost of Material Consumed493.38386.59340.71307.56270.74
Internally Manufactured Intermediates Consumed0.000.000.000.000.00
Purchases of Stock-in-Trade0.000.000.000.000.00
Employee Benefits122.9287.4670.3263.4158.32
Total Other Expenses 70.9969.2257.0746.8140.18
Manufacturing / Operating Expenses33.1826.6721.5319.9619.91
Administrative and Selling Expenses33.5335.9230.1323.0815.09
Other Expenses4.286.635.413.785.18
Finance Costs4.381.100.791.421.29
Depreciation and Amortization27.9913.4412.3612.1512.97
Total Expenses698.13567.40465.99426.60387.17
Profit Before Exceptional Items and Tax79.3977.0257.0646.0443.53
Exceptional Items Before Tax0.000.000.000.00-32.35
Profit Before Extraordinary Items and Tax79.3977.0257.0646.0411.18
Extraordinary Items Before Tax0.000.000.000.000.00
Other Adjustments Before Tax0.000.000.000.000.00
Profit Before Tax79.3977.0257.0646.0411.18
Taxation18.7518.8814.417.486.17
Current Tax18.2717.3414.3510.134.84
MAT Credit Entitlement0.000.000.000.000.00
Deferred Tax0.471.540.06-2.661.33
Other Tax0.000.000.000.000.00
Adjust for Previous Year0.000.000.000.000.00
Profit After Tax60.6558.1442.6438.565.01
Extraordinary Items After Tax0.000.000.000.000.00
Discontinued Operations After Tax0.000.000.000.000.00
Profit / (Loss) from Discontinuing Operations0.000.000.000.000.00
Tax Expenses of Discontinuing Operations0.000.000.000.000.00
Profit Attributable to Shareholders60.6558.1442.6438.565.01
Adjustments to Net Income0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Profit Attributable to Equity Shareholders60.6558.1442.6438.565.01
Earning Per Share - Basic29.0327.9519.7118.812.75
Earning Per Share - Diluted28.7127.8619.7118.812.75

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +